权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Population Sciences

人口科学

基本信息

批准号：
10626953
负责人：
ESTHER M. JOHN
金额：
$ 6.67万
依托单位：
STANFORD UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
起止时间：
2007-06-04 至 2027-05-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10626953
关键词：
Address Age Applications Grants Behavioral Behavioral Sciences Big Data Bioinformatics Body Composition Breast Breast Cancer Genetics COVID-19 complications Cancer Burden Cancer Etiology Cancer Patient Cancer health equity Caregivers Catchment Area Clinical Clinical Sciences Collaborations Collection Colon Communication Communities Community Health Community Outreach Computerized Medical Record Data Set Detection Diagnosis Diet Disease Progression Effectiveness Environmental Exposure Epidemiology Ethnic Origin Etiology Faculty Family Cancer History Funding Future Gender Genes Genetic Genetic Risk Geography Goals Grant Guidelines Health Health Policy Health Services Incidence Institution International Intervention Intervention Studies Intervention Trial Journals K-Series Research Career Programs Lead Leadership Legal Life Cycle Stages Life Style Liver Longevity Lung Lymphoma Machine Learning Malignant Neoplasms Malignant neoplasm of lung Manuscripts Medicare Mentors Metabolic Methods Minor Mobile Health Application Modeling Molecular Morbidity - disease rate NCI-Designated Cancer Center Neoplasm Metastasis Obesity Observational Study Outcome Palliative Care Pancreas Pathogenicity Patients Peer Review Physical activity Population Population Heterogeneity Population Sciences Practice Guidelines Prevention Prevention Research Prognostic Factor Prostate Public Health Publishing Quality of life Race Rectum Recurrence Research Research Personnel Research Priority Resource Sharing Risk Factors Risk Reduction Sales Scientist Screening for cancer Second Primary Cancers Sexual and Gender Minorities Shapes Sleep Socioeconomic Status Stress Symptoms Testing Tobacco Tobacco use Training Training Programs Translational Research Treatment Factor United States National Institutes of Health Variant adverse outcome behavior change brca gene cancer care cancer health disparity cancer prevention cancer risk cancer therapy clinical care clinical decision-making clinical development clinical practice community engagement comorbidity computed tomography screening cost effective data mining data resource efficacy testing end of life end of life care genetic epidemiology genetic risk assessment genetic testing high risk population implementation science improved improved outcome innovation lifestyle intervention member mortality multidisciplinary new technology next generation nicotine use novel peer support personalized approach pre-clinical programs recruit rectal risk prediction risk prediction model screening sedentary sex social determinants social health determinants survivorship tobacco control tobacco products tobacco user treatment response working group

项目摘要

PROJECT SUMMARY The goal of the Population Sciences Program (PS) of the Stanford Cancer Institute (SCI) is to conduct high- impact transdisciplinary and translational research across the cancer continuum aimed at improving detection through screening, reducing cancer incidence, morbidity and mortality, and improving cancer outcomes. The PS achieves this goal by promoting and facilitating innovative multidisciplinary observational and interventional research on cancer that will impact public health and guide clinical practice and health policy. PS members are nationally and internationally recognized clinical and population scientists with a broad range of unique strengths in epidemiology, genetics, quantitative modeling, bioinformatics, use of novel technologies, behavioral science, lifestyle (physical activity, diet, tobacco control, sleep), and clinical and palliative care interventional trials, and community health and prevention research. The program’s overarching research priorities include reducing the cancer burden and disparities (by age, sex and gender, race and ethnicity, socioeconomic status, geography, and other social determinants of health) in the highly diverse population of SCI’s catchment area. PS members’ research addresses the following Specific Aims: Aim 1: Conduct research on cancer etiology, risk prediction, screening, and genetic testing; Aim 2: Investigate the impact of cancer treatment and prognostic factors on outcomes; and Aim 3: Conduct intervention research to reduce cancer risks and improve outcomes. The PS has 39 members, of whom 31 are supported by peer-reviewed funding totaling $14.0M, including $7.4M from the NCI, $5.0M other cancer-relevant NIH support, and $1.6M from other peer-reviewed support. During the current funding period, PS members published 1,130 peer-reviewed manuscripts. Of these, 22% are intra- programmatic, 23% are inter-programmatic, 96% are multi-institutional, and 18% are in journals with an impact factor of 10 or higher. Support from the SCI has been instrumental in promoting both intra- and inter- programmatic collaborations of PS members, recruiting new faculty members, and enabling preliminary research through innovation grants that lead to externally funded projects. PS members also strive to train the next generation of cancer prevention researchers. In the future, the PS will further expand and focus on research in genetic risk profiling and assessment, outcomes and survivorship research across the life course, cancer in sexual and gender minorities, and health services and implementation science, and will develop and submit a T32 training grant in genetic epidemiology and population sciences.

项目总结斯坦福大学癌症研究所(SCI)人口科学计划(PS)的目标是进行高- 跨癌症的跨学科和转化性研究旨在提高检测水平通过筛查，降低癌症发病率、发病率和死亡率，并改善癌症结果。The PS 通过促进和促进创新的多学科观察性和干预性来实现这一目标对癌症的研究将影响公众健康，并指导临床实践和卫生政策。PS成员是具有广泛独特优势的国内和国际公认的临床和人口科学家在流行病学、遗传学、定量建模、生物信息学、新技术的使用、行为科学、生活方式(体力活动、饮食、控烟、睡眠)、临床和姑息治疗干预试验，以及社区卫生和预防研究。该计划的首要研究重点包括减少癌症负担和差异(按年龄、性别和性别、种族和民族、社会经济地位、地理位置、和其他健康的社会决定因素)在SCI集水区高度多样化的人口中。 PS成员的研究涉及以下具体目标：目标1：进行癌症病因学、风险研究预测、筛查和基因测试；目标2：调查癌症治疗和预后的影响影响结果的因素；以及目标3：开展干预研究以降低癌症风险和改善结果。 PS有39名成员，其中31名由同行审查资助，总额为1400万美元，其中包括740万美元来自NCI的500万美元其他与癌症相关的NIH支持，以及来自其他同行评议支持的160万美元。在.期间在目前的资助期内，社会保障局成员发表了1130份同行评议的手稿。其中，22%是内部的计划性的，23%是跨计划的，96%是多机构的，18%是有影响的期刊因数为10或更高。SCI的支持有助于促进内部和外部的 PS成员的计划协作，招聘新的教员，并支持初步研究通过创新赠款引导外部资助的项目。PS成员也在努力培训下一位一代癌症预防研究人员。未来，PS将进一步扩大并专注于整个生命过程中的遗传风险描述和评估，结果和生存研究，癌症性少数群体和性别少数群体以及保健服务和执行科学，并将制定和提交一份遗传流行病学和人口科学方面的T32培训补助金。